Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 1/2
This study is looking at a drug called G1T38 with fulvestrant for breast cancer that has spread (advanced breast cancer).
It is open to people with advanced breast cancer that has continued to get worse while having hormone therapy.
Recruitment start: 1 January 2017
Recruitment end: 2 August 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Roylance
G1 Therapeutics
University College London Hospitals NHS Foundation Trust
Last reviewed: 03 Sept 2019
CRUK internal database number: 15500
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
